Last reviewed · How we verify

NCT06012526

The Study of Sleep Disordered Breathing in Patients With Interstitial Lung Diseases

Completed Last updated 25 August 2023
What this trial tests

trial testing Polysomnography in Obstructive Sleep Apnea-hypopnea in 69 participants. Completed in 24 July 2022.

Timeline
25 November 2020
Primary endpoint
20 April 2022
24 July 2022

Quick facts

Lead sponsorBeni-Suef University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment69
Start date25 November 2020
Primary completion20 April 2022
Estimated completion24 July 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 18 to 90, any sex, with Obstructive Sleep Apnea-hypopnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a cross-sectional observational study to evaluate the prevalence and predictive factors of SDB in ILD and to analyze the relationship between polysomnography (PSG) findings, pulmonary function, disease severity, parenchymal involvement, and sleep questionnaires ESS and SBQ. This study included 69 patients who were diagnosed with diffuse parenchymal lung diseases by high-resolution computed tomography (HRCT) chest. All patients were subjected to clinical examination, HRCT, spirometry, full-night polysomnography, and echocardiography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Polysomnography

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea-hypopnea

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06012526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing